Works matching IS 17762596 AND DT 2023 AND VI 18 AND IP 1

Results: 9

Clinical Outcomes After Progression on First-Line Therapies in IDH1 Mutated Versus Wild-Type Intrahepatic Cholangiocarcinoma Patients.
Published in:
Targeted Oncology, 2023, v. 18, n. 1, p. 139, doi. 10.1007/s11523-022-00933-7
By:
- Rimini, Margherita;
- Fabregat-Franco, Carles;
- Persano, Mara;
- Burgio, Valentina;
- Bergamo, Francesca;
- Niger, Monica;
- Scartozzi, Mario;
- Rapposelli, Ilario Giovanni;
- Aprile, Giuseppe;
- Ratti, Francesca;
- Pedica, Federica;
- Verdaguer, Helena;
- Rizzato, Mario;
- Nichetti, Federico;
- Lai, Eleonora;
- Cappetta, Alessandro;
- Macarulla, Teresa;
- Fassan, Matteo;
- De Braud, Filippo;
- Pretta, Andrea
Publication type:
Article
Selpercatinib: A Review in Advanced RET Fusion-Positive NSCLC.
Published in:
Targeted Oncology, 2023, v. 18, n. 1, p. 169, doi. 10.1007/s11523-022-00935-5
By:
- Nie, Tina;
- Syed, Yahiya Y.
Publication type:
Article
Impact of KRAS Mutations on Clinical Outcomes of Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer Receiving Anti-PD-1/PD-L1 Therapy.
Published in:
Targeted Oncology, 2023, v. 18, n. 1, p. 129, doi. 10.1007/s11523-022-00934-6
By:
- Veccia, Antonello;
- Dipasquale, Mariachiara;
- Kinspergher, Stefania;
- Monteverdi, Sara;
- Girlando, Salvatore;
- Barbareschi, Mattia;
- Caffo, Orazio
Publication type:
Article
Coadministration of Apalutamide and Relugolix in Patients with Localized Prostate Cancer at High Risk for Metastases.
Published in:
Targeted Oncology, 2023, v. 18, n. 1, p. 95, doi. 10.1007/s11523-022-00932-8
By:
- Brown, Gordon;
- Belkoff, Laurence;
- Hafron, Jason M.;
- Saltzstein, Daniel R.;
- Potdar, Rushikesh;
- Bhaumik, Amitabha;
- Phillips, Jennifer;
- McGowan, Tracy;
- Shore, Neal D.
Publication type:
Article
Phase I Study Evaluating Glesatinib (MGCD265), An Inhibitor of MET and AXL, in Patients with Non-small Cell Lung Cancer and Other Advanced Solid Tumors.
Published in:
Targeted Oncology, 2023, v. 18, n. 1, p. 105, doi. 10.1007/s11523-022-00931-9
By:
- Kollmannsberger, Christian;
- Hurwitz, Herbert;
- Bazhenova, Lyudmila;
- Cho, Byoung Chul;
- Hong, David;
- Park, Keunchil;
- Reckamp, Karen L.;
- Sharma, Sunil;
- Der-Torossian, Hirak;
- Christensen, James G.;
- Faltaos, Demiana;
- Potvin, Diane;
- Tassell, Vanessa;
- Chao, Richard;
- Shapiro, Geoffrey I.
Publication type:
Article
Recent Evidence-Based Clinical Guide for the Use of Dinutuximab Beta in Pediatric Patients with Neuroblastoma.
Published in:
Targeted Oncology, 2023, v. 18, n. 1, p. 77, doi. 10.1007/s11523-022-00930-w
By:
- Balaguer, Julia;
- García Hidalgo, Laura;
- Hladun, Raquel;
- Márquez Vega, Catalina;
- Pérez Alonso, Vanesa
Publication type:
Article
Clinical Outcomes of First Subsequent Therapies After Abiraterone Acetate Plus Prednisone for High-Risk Metastatic Castration-Sensitive Prostate Cancer in the LATITUDE Study.
Published in:
Targeted Oncology, 2023, v. 18, n. 1, p. 119, doi. 10.1007/s11523-022-00929-3
By:
- Koroki, Yosuke;
- Taguri, Masataka
Publication type:
Article
Correction to: The Difference in Clinical Outcomes Between Osimertinib and Afatinib for First-Line Treatment in Patients with Advanced and Recurrent EGFR-Mutant Non-Small Cell Lung Cancer in Taiwan.
Published in:
2023
By:
- Huang, Yen-Hsiang;
- Hsu, Kuo-Hsuan;
- Tseng, Jeng-Sen;
- Yang, Tsung-Ying;
- Chen, Kun-Chieh;
- Su, Kang-Yi;
- Yu, Sung-Liang;
- Chen, Jeremy J. W.;
- Chang, Gee-Chen
Publication type:
Correction Notice
Current and Future Perspectives of Health-Related Quality of Life in Resectable EGFR-Mutated Non-Small Cell Lung Cancer: A Podcast.
Published in:
2023
By:
- John, Thomas;
- Majem, Margarita;
- Legg, Diane;
- Goldman, Jonathan
Publication type:
Letter